PE21995A1 - Derivado de 2-carboxiindol - Google Patents

Derivado de 2-carboxiindol

Info

Publication number
PE21995A1
PE21995A1 PE1994252640A PE25264094A PE21995A1 PE 21995 A1 PE21995 A1 PE 21995A1 PE 1994252640 A PE1994252640 A PE 1994252640A PE 25264094 A PE25264094 A PE 25264094A PE 21995 A1 PE21995 A1 PE 21995A1
Authority
PE
Peru
Prior art keywords
derivative
adylene
carboxyindol
amino
stricnin
Prior art date
Application number
PE1994252640A
Other languages
English (en)
Inventor
Alfredo Cugola
Giorgio Pentassuglia
Di Fabio Romano
Original Assignee
Glaxo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Spa filed Critical Glaxo Spa
Publication of PE21995A1 publication Critical patent/PE21995A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

SE REFIERE A UN DERIVADO DE INDOL DE FORMULA I DONDE: 1) R ES HALOGENO, ALQUILO, ALCOXI, AMINO, ALQUILAMINO Y OTROS, DE PREFERENCIA ES CLORO; 2) R1 ES CICLOALQUILO, HETEROARILO, HETEROCICLO, FENILO, CARBOCICLO BICICLICO FUSIONADO, DE PREFERENCIA FENILO OPCIONALMENTE SUSTITUIDO, 1-NAFTILO, 2-PIRIDILO, QUINOLINILO, CICLOHEXILO, 2-ADAMANTILO; 3) A ES -(CH2)2-, -(CH2)3-, -CH2CO-, -CH2NH-, -CH2-N(CH3)-, -(CH2)2-NH-, -NHCO-, -CH2O-, 4) m VARIA DE 0 A 2; EL CUAL PUEDE SER ANTAGONISTA DE AMINOACIDOS EXCITADORES EN EL SITIO DE UNION DE LA GLICINA INSENSIBLE A ESTRICNINA LOCALIZADO SOBRE EL COMPLEJO DEL RECEPTOR DE N-METIL-D-ASPARTATO (NMDA), SIENDO UTIL EN EL TRATAMIENTO DE DANO NEUROTOXICO O ENFERMEDADES NEURODEGENERATIVAS
PE1994252640A 1993-10-14 1994-10-12 Derivado de 2-carboxiindol PE21995A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939321221A GB9321221D0 (en) 1993-10-14 1993-10-14 Heterocyclic compounds

Publications (1)

Publication Number Publication Date
PE21995A1 true PE21995A1 (es) 1995-08-14

Family

ID=10743550

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1994252640A PE21995A1 (es) 1993-10-14 1994-10-12 Derivado de 2-carboxiindol

Country Status (27)

Country Link
US (3) US5760059A (es)
EP (1) EP0723541A1 (es)
JP (1) JPH09503770A (es)
CN (1) CN1070490C (es)
AP (1) AP574A (es)
AU (1) AU681194B2 (es)
BG (1) BG61839B1 (es)
CA (1) CA2171449A1 (es)
CO (1) CO4290355A1 (es)
CZ (1) CZ92396A3 (es)
FI (1) FI961628A (es)
GB (1) GB9321221D0 (es)
HU (1) HU219710B (es)
IL (1) IL111294A (es)
IS (1) IS4219A (es)
MY (1) MY112411A (es)
NO (1) NO309861B1 (es)
NZ (1) NZ274179A (es)
OA (1) OA10578A (es)
PE (1) PE21995A1 (es)
PL (1) PL179568B1 (es)
RU (1) RU2144535C1 (es)
SG (1) SG49013A1 (es)
SK (1) SK44996A3 (es)
TW (1) TW283144B (es)
WO (1) WO1995010517A1 (es)
ZA (1) ZA947948B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9321221D0 (en) * 1993-10-14 1993-12-01 Glaxo Spa Heterocyclic compounds
GB9704498D0 (en) * 1997-03-05 1997-04-23 Glaxo Wellcome Spa Chemical compound
GB9704499D0 (en) * 1997-03-05 1997-04-23 Glaxo Wellcome Spa Method of manufacture
JP2002540098A (ja) * 1999-03-23 2002-11-26 住友製薬株式会社 三環性インドール−2−カルボン酸化合物
DE10153346A1 (de) 2001-10-29 2004-04-22 Grünenthal GmbH Substituierte Indole
US20030162825A1 (en) * 2001-11-09 2003-08-28 Sepracor Inc. D-amino acid oxidase inhibitors for learning and memory
PL380887A1 (pl) 2003-12-29 2007-04-02 Sepracor Inc. Pirolowe i pirazolowe inhibitory DAAO
EP1904066B1 (en) 2005-07-06 2018-05-23 Sunovion Pharmaceuticals Inc. COMBINATIONS OF ESZOPICLONE AND TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-N-METHYL-1-NAPTHALENAMINE OR TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPTHALENAMINE, for treating MENOPAUSE, perimenopause AND COGNITIVE DISORDERS
US20070203111A1 (en) 2006-01-06 2007-08-30 Sepracor Inc. Cycloalkylamines as monoamine reuptake inhibitors
CN104276955A (zh) * 2006-01-06 2015-01-14 赛诺维信制药公司 基于四氢萘酮的单胺再摄取抑制剂
ES2555315T3 (es) 2006-03-31 2015-12-30 Sunovion Pharmaceuticals Inc. Preparación de amidas y aminas quirales
US7884124B2 (en) * 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
US7579370B2 (en) * 2006-06-30 2009-08-25 Sepracor Inc. Fused heterocycles
US20080082066A1 (en) * 2006-10-02 2008-04-03 Weyerhaeuser Co. Crosslinked carboxyalkyl cellulose fibers having non-permanent and temporary crosslinks
CA2676432A1 (en) * 2007-01-18 2008-07-24 Sepracor, Inc. Inhibitors of d-amino acid oxidase
US7902252B2 (en) * 2007-01-18 2011-03-08 Sepracor, Inc. Inhibitors of D-amino acid oxidase
MX2009012685A (es) 2007-05-31 2009-12-14 Sepracor Inc Cicloalquilaminas sustituidas con fenilo como inhibidores de la reabsorcion de monoamina.
WO2010017418A1 (en) * 2008-08-07 2010-02-11 Sepracor Inc. Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
EA201101307A1 (ru) * 2009-03-10 2012-03-30 Сантен Фармасьютикал Ко., Лтд. Профилактические или терапевтические средства для расстройств зрительного нерва, содержащие производные 4,6-дихлор-1н-индол-2-карбоновой кислоты или их соли в качестве активных ингредиентов
WO2011017634A2 (en) * 2009-08-07 2011-02-10 Sepracore Inc. Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
CA2850707C (en) 2011-10-03 2023-03-21 The University Of Utah Research Foundation Application of 5-ht6 receptor antagonists for the alleviation of cognitive deficits of down syndrome
PT3137658T (pt) 2014-04-30 2022-05-05 Univ Nat Taiwan Uso de compostos conhecidos como inibidores do d-aminoácido oxidase
WO2018053161A1 (en) 2016-09-14 2018-03-22 National Taiwan University Novel substituted benzimidazole derivatives as d-amino acid oxidase (daao) inhibitors

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256673A (en) * 1983-11-25 1993-10-26 Merck Patent Gesellschaft Mit Beschrankter Haftung Indole-3-yl-A-tetrahydropyridyl or piperidyl compounds
US4960786A (en) * 1989-04-24 1990-10-02 Merrell Dow Pharmaceuticals Inc. Excitatory amino acid antagonists
DE4101686A1 (de) * 1991-01-22 1992-07-23 Merck Patent Gmbh Indolderivate
US5284862A (en) * 1991-03-18 1994-02-08 Warner-Lambert Company Derivatives of 2-carboxyindoles having pharmaceutical activity
US5145845A (en) * 1991-05-14 1992-09-08 Warner-Lambert Co. Substituted 2-carboxylindoles having pharmaceutical activity
EP0545478A1 (en) * 1991-12-03 1993-06-09 MERCK SHARP & DOHME LTD. Heterocyclic compounds as tachykinin antagonists
GB9208492D0 (en) * 1992-04-16 1992-06-03 Glaxo Spa Heterocyclic compounds
CZ181493A3 (en) * 1992-09-10 1994-03-16 Lilly Co Eli The use of rhodanine derivative for the preparation of a pharmaceutical composition reducing level of sugar in blood and for treating alzheimer's disease
DE4333254A1 (de) * 1993-09-30 1995-04-06 Merck Patent Gmbh Piperidine und Piperazine
GB9321221D0 (en) * 1993-10-14 1993-12-01 Glaxo Spa Heterocyclic compounds

Also Published As

Publication number Publication date
AP9400685A0 (en) 1994-10-31
HU219710B (hu) 2001-06-28
IL111294A0 (en) 1994-12-29
JPH09503770A (ja) 1997-04-15
AU681194B2 (en) 1997-08-21
NO961475L (no) 1996-04-12
BG61839B1 (bg) 1998-07-31
MY112411A (en) 2001-06-30
CO4290355A1 (es) 1996-04-17
TW283144B (es) 1996-08-11
BG100511A (en) 1996-11-29
SG49013A1 (en) 1998-05-18
HUT76065A (en) 1997-06-30
EP0723541A1 (en) 1996-07-31
CN1070490C (zh) 2001-09-05
CN1133042A (zh) 1996-10-09
NO961475D0 (no) 1996-04-12
RU2144535C1 (ru) 2000-01-20
ZA947948B (en) 1995-05-23
GB9321221D0 (en) 1993-12-01
WO1995010517A1 (en) 1995-04-20
HU9600969D0 (en) 1996-06-28
PL179568B1 (pl) 2000-09-29
IS4219A (is) 1995-04-15
IL111294A (en) 1998-12-06
CA2171449A1 (en) 1995-04-20
AP574A (en) 1997-01-30
NO309861B1 (no) 2001-04-09
NZ274179A (en) 1998-01-26
FI961628A0 (fi) 1996-04-12
US6100289A (en) 2000-08-08
AU7813394A (en) 1995-05-04
OA10578A (en) 2002-06-07
SK44996A3 (en) 1997-01-08
US5962496A (en) 1999-10-05
FI961628A (fi) 1996-04-12
US5760059A (en) 1998-06-02
PL313969A1 (en) 1996-08-05
CZ92396A3 (en) 1996-08-14

Similar Documents

Publication Publication Date Title
PE21995A1 (es) Derivado de 2-carboxiindol
PE20010741A1 (es) Derivados de piperazina como antagonistas de taquicininas
DE69319235T2 (de) Perhydroisoindole derivate als substanz p antagonisten
PE91798A1 (es) Pirrolicarboxanilidas condensadas: utiles como ligandos receptores
PE20010930A1 (es) Bifenil sulfonamidas como antagonistas de receptores de angiotensina endotelina duales
FI913503A0 (fi) Bensimidazoler, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning.
DE69613347D1 (de) Bizyklisch substituierte hexahydrobenz(e)isoindole mit alpha-1-adrenerg antagonistischer wirkung
EA200300717A1 (ru) Гетероциклилиндазольные и -азаиндазольные соединения в качестве 5-гидрокситриптамин-6-лигандов
DE69230013T2 (de) Fibrinogen-Rezeptor-Antagonisten
ATE163646T1 (de) Fibrinogen-rezeptor-antagonisten
FI935071A (fi) Nya perhydroisoindoler, deras framstaellning och dessa innehaollande farmaceutiska preparat
DE69131311D1 (de) Fibrinogen-Rezeptor-Antagonisten
YU45293A (sh) Morfolin i tiomorfolin tahikinin antagonisti receptora
NZ510551A (en) Substituted 3-cyanoquinolines useful as protein tyrosine kinases inhibitors
ATE219077T1 (de) Endothelin antagoniste
DE69422303T2 (de) Neue 4-piperidinyl substituierte lactame als neukokinin 2 rezeptor antagonisten zur behandlung von asthma
DE69017593D1 (de) Substituierte N-(Imidazolyl)alkyl-alanin-Derivate.
PE69398A1 (es) Antagonistas de receptor de benzoxazinona dopamina d4
TR200001182T2 (tr) Yeni karbonik asit türevleri, üretimleri ve kullanımları.
TR199802552T2 (xx) 5-HT-2C Resept�r kar��tlar� olarak faydal� indolin t�revleri.
DE3787796D1 (de) Anwendung heterozyklischer Derivate zur Herstellung von Arzneimitteln.
ATE424411T1 (de) Varianten von säugerprolactin
MX9603199A (es) Antagonistas de receptores a endotelina.
ATE194988T1 (de) Bicyclische nonan-und decanverbindungen mit dopamine-rezeptor-affinitaet
ATE415390T1 (de) Neue aminopyridinderivate als mglur5-antagonisten

Legal Events

Date Code Title Description
AE Restoration of lapsed or forfeited application
FG Grant, registration
FD Application declared void or lapsed